Patents by Inventor Eric H. Schroeter

Eric H. Schroeter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8431768
    Abstract: A system including: (i) a methodology for targeted cellular ablation in zebrafish; (ii) a methodology for regional cellular ablation in zebrafish. These methodologies are used to identify drug compounds that influence cellular regeneration for the purpose of developing therapies for degenerative conditions. Transgenic zebrafish disclosed herein contain transgenic constructs composed of: (i) cell and/or tissue-type specific regulatory elements (e.g. promoter and/or enhancer regions) which delimit expression of operably linked gene product(s) to discrete cellular populations; (ii) a gene product that promotes cellular ablation composed of a pro-drug conversion system capable of converting nontoxic pro-drugs into cytotoxic drugs, which is expressed alone or in connection with; (iii) a reporter gene product that allows selective detection of cells expressing the reporter—both prior to (initial cells) and following cellular ablation (regenerated cells).
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: April 30, 2013
    Assignee: Washington University
    Inventors: Jeffrey S. Mumm, Eric H. Schroeter
  • Publication number: 20120144505
    Abstract: A system including: (i) a methodology for targeted cellular ablation in zebrafish; (ii) a methodology for regional cellular ablation in zebrafish. These methodologies are used to identify genetic components that regulate cellular regeneration and to identify drug compounds that influence cellular regeneration for the purpose of developing therapies for degenerative conditions. Transgenic zebrafish disclosed herein contain transgenic constructs composed of: (i) cell and/or tissue-type specific regulatory elements (e.g.
    Type: Application
    Filed: November 2, 2011
    Publication date: June 7, 2012
    Applicant: WASHINGTON UNIVERSITY IN ST. LOUIS
    Inventors: Jeffrey S. Mumm, Eric H. Schroeter
  • Patent number: 8071838
    Abstract: A system including: (i) a methodology for targeted cellular ablation in zebrafish; (ii) a methodology for regional cellular ablation in zebrafish. These methodologies are used to identify genetic components that regulate cellular regeneration and to identify drug compounds that influence cellular regeneration for the purpose of developing therapies for degenerative conditions. Transgenic zebrafish disclosed herein contain transgenic constructs composed of: (i) cell and/or tissue-type specific regulatory elements (e.g.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: December 6, 2011
    Assignee: Washington University in St. Louis
    Inventors: Jeffrey S. Mumm, Eric H. Schroeter
  • Publication number: 20100223679
    Abstract: A system including: (i) a methodology for targeted cellular ablation in zebrafish; (ii) a methodology for regional cellular ablation in zebrafish. These methodologies are used to identify genetic components that regulate cellular regeneration and to identify drug compounds that influence cellular regeneration for the purpose of developing therapies for degenerative conditions. Transgenic zebrafish disclosed herein contain transgenic constructs composed of: (i) cell and/or tissue-type specific regulatory elements (e.g.
    Type: Application
    Filed: February 27, 2009
    Publication date: September 2, 2010
    Applicant: Washington University in St. Louis
    Inventors: Jeffrey S. Mumm, Eric H. Schroeter
  • Patent number: 7514595
    Abstract: A system including: (i) a methodology for targeted cellular ablation in zebrafish; (ii) a methodology for regional cellular ablation in zebrafish. These methodologies are used to identify genetic components that regulate cellular regeneration and to identify drug compounds that influence cellular regeneration for the purpose of developing therapies for degenerative conditions. Transgenic zebrafish disclosed herein contain transgenic constructs composed of: (i) cell and/or tissue-type specific regulatory elements (e.g.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 7, 2009
    Assignee: Washington University in St. Louis
    Inventors: Jeffrey S. Mumm, Eric H. Schroeter
  • Publication number: 20040261143
    Abstract: A system including: (i) a methodology for targeted cellular ablation in zebrafish; (ii) a methodology for regional cellular ablation in zebrafish. These methodologies are used to identify genetic components that regulate cellular regeneration and to identify drug compounds that influence cellular regeneration for the purpose of developing therapies for degenerative conditions. Transgenic zebrafish disclosed herein contain transgenic constructs composed of: (i) cell and/or tissue-type specific regulatory elements (e.g.
    Type: Application
    Filed: March 12, 2004
    Publication date: December 23, 2004
    Inventors: Jeffrey S. Mumm, Eric H. Schroeter